- Home
- PYXS
PYXS
Pyxis Oncology Inc.
as of 12-09-2025 11:49am EST
$4.35
+$0.17
+4.07%
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
Chart Type:
Time Range:
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | BOSTON |
| Market Cap: | 243.5M | IPO Year: | 2021 |
| Target Price: | $7.00 | AVG Volume (30 days): | 786.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.57 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.83 - $5.55 | Next Earning Date: | 11-03-2025 |
| Revenue: | $2,820,000 | Revenue Growth: | -82.53% |
| Revenue Growth (this year): | -82.24% | Revenue Growth (next year): | N/A |
AI-Powered PYXS Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 18 hours ago
AI Recommendation
hold
Model Accuracy: 68.21%
68.21%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Pyxis Oncology Inc. News
PYXS Breaking Stock News: Dive into PYXS Ticker-Specific Updates for Smart Investing
Compare PYXS vs Leading Stocks
See how PYXS stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "PYXS Pyxis Oncology Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.